Zobrazeno 1 - 10
of 206
pro vyhledávání: '"PACE Investigators"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Karen D Kirke
Publikováno v:
Journal of Health Psychology. 22:1168-1176
The PACE investigators’ citation of a patient survey might mislead readers into thinking that the experience of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) supports PACE findings. In fact, patient survey evidence directl
Autor:
Boehmer AA; St Josefs-Hospital, Wiesbaden, Germany., Kaess BM; St Josefs-Hospital, Wiesbaden, Germany., Ruckes C; Interdisciplinary Center for Clinical Trials, University Medical Center, Mainz, Germany., Meyer C; Evangelical Hospital, Duesseldorf, Germany., Metzner A; University Hospital of Hamburg-Eppendorf, Hamburg, Germany., Rillig A; University Hospital of Hamburg-Eppendorf, Hamburg, Germany., Eckardt L; Department of Cardiology II-Electrophysiology, University Hospital Münster, Münster, Germany., Nattel S; Montréal Heart Institute, Montréal, Québec, Canada., Ehrlich JR; St Josefs-Hospital, Wiesbaden, Germany. Electronic address: jehrlich@joho.de.
Publikováno v:
The Canadian journal of cardiology [Can J Cardiol] 2024 Jul 25. Date of Electronic Publication: 2024 Jul 25.
Autor:
Cortes, JE, Kim, D-W, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, FE, Apperley, JF, Khoury, HJ, Talpaz, M, DiPersio, J, DeAngelo, DJ, Abruzzese, E, Rea, D, Baccarani, M, Müller, MC, Gambacorti-Passerini, C, Wong, S, Lustgarten, S, Rivera, VM, Clackson, T, Turner, CD, Haluska, FG, Guilhot, F, Deininger, MW, Hochhaus, A, Hughes, T, Goldman, JM, Shah, NP, Kantarjian, H, PACE Investigators
Publikováno v:
The New England journal of medicine, vol 369, iss 19
BackgroundPonatinib is a potent oral tyrosine kinase inhibitor of unmutated and mutated BCR-ABL, including BCR-ABL with the tyrosine kinase inhibitor-refractory threonine-to-isoleucine mutation at position 315 (T315I). We conducted a phase 2 trial of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::7cc75f7e4e51a4a96142790ddee69076
https://escholarship.org/uc/item/6s61b8vf
https://escholarship.org/uc/item/6s61b8vf
Autor:
Tuller, David
Publikováno v:
Journal of Health Psychology; Aug2017, Vol. 22 Issue 9, p1118-1122, 5p
Autor:
Lubet, Steven
Publikováno v:
Journal of Health Psychology; Aug2017, Vol. 22 Issue 9, p1123-1127, 5p
Autor:
Cortes, Je1, Kim, Dw, Pinilla Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, Fe, Apperley, Jf, Khoury, Hj, Talpaz, M, Dipersio, J, Deangelo, Dj, Abruzzese, E, Rea, D, Baccarani, M, Müller, Mc, Gambacorti Passerini, C, Wong, S, Lustgarten, S, Rivera, Vm, Clackson, T, Turner, Cd, Haluska, Fg, Guilhot, F, Deininger, Mw, Hochhaus, A, Hughes, T, Goldman, Jm, Shah, Np, Kantarjian, H, Pace, Investigators, Saglio, Giuseppe
Background Ponatinib is a potent oral tyrosine kinase inhibitor of unmutated and mutated BCR-ABL, including BCR-ABL with the tyrosine kinase inhibitor–refractory threonineto-isoleucine mutation at position 315 (T315I). We conducted a phase 2 trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::468aaf98e550898d3a82c26fd1a09826
http://hdl.handle.net/10281/52070
http://hdl.handle.net/10281/52070
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jouven X; African Research Network, European Georges Pompidou Hospital, Paris, France; University of Paris, Paris, France; Global Health Unit, Paris Cardiovascular Research Center (INSERM U970), Paris, France. Electronic address: xavier.jouven@inserm.fr., Diop BI; Fann Hospital, Dakar, Senegal., Narayanan K; Global Health Unit, Paris Cardiovascular Research Center (INSERM U970), Paris, France; Medicover Hospitals, Hyderabad, India., Adoubi A; Abidjan Heart Institute, Abidjan, Ivory Coast., Ba SA; Aristide Le Dantec University Hospital, Dakar, Senegal., Balde D; Conakry University Hospital, Conakry, Guinea., Damorou JM; Lomé University Hospital, Lomé, Togo., Diarra MB; Kati University Hospital, Bamako, Mali., Dzudie A; General Douala Hospital, Douala, Cameroon., Ferreira B; Maputo Heart Institute, Maputo, Mozambique., Houenassi SM; Cotonou University Hospital, Cotonou, Benin., Ikama MS; University Brazzaville Hospital, Brazzaville, Republic of the Congo., Kane A; Grand-Yoff Hospital, Dakar, Senegal., Kane A; Saint Louis University Hospital, Saint Louis, Senegal., Kingue S; General Douala Hospital, Douala, Cameroon., Mipinda JB; Libreville University Hospital, Libreville, Gabon., Mocumbi AO; Instituto Nacional de Saúde, Maputo, Mozambique., Niakara A; Polyclinique Internationale de Ouagadougou, Kadiogo, Burkina Faso., Ouankou M; Kati University Hospital, Bamako, Mali., Aly Sidi A; University Hospital, Nouakchott, Mauritania., Takombe JL; Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo., Toure IA; Niamey National Hospital, Niamey, Niger., Zabsonré P; Ouagadougou University Hospital, Ouagadougou, Burkina Faso., Celermajer DS; Sydney Medical School, Sydney, New South Wales, Australia., Lafont A; African Research Network, European Georges Pompidou Hospital, Paris, France; University of Paris, Paris, France., Dodinot B; African Research Network, European Georges Pompidou Hospital, Paris, France., Sagnol P; African Research Network, European Georges Pompidou Hospital, Paris, France., Marijon E; African Research Network, European Georges Pompidou Hospital, Paris, France; University of Paris, Paris, France; Global Health Unit, Paris Cardiovascular Research Center (INSERM U970), Paris, France.
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2019 Nov 26; Vol. 74 (21), pp. 2652-2660.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.